Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.

Researchers are slowly tossing much of what we've been told for many years about Alzheimer's disease out the window — and replacing what has been a very dreary tale with new findings.

For AAA developers, it's often all about the biggest franchises, the safest sequels. We have industry auteurs like Suda 51, ...

Bay Clinic of Chiropractic in Panama City, Florida, is expanding its comprehensive functional medicine services to meet growing demand for root-cause healthcare solutions as chronic health conditions ...

Live Science spoke with Dr. Joe Alexander of NTT Research about "digital twins" and the development of an autonomous device ...

Ring in the new year with free programming at the library! The library will be closed Jan. 1 and Jan. 19. Lunchtime book club ...

Today, China ranks second only to the United States in the number of new drugs under development, with its pipeline ...

A $30 million federal research initiative is taking aim at one of drug development’s most stubborn and costly blind spots: ...

Researchers found a genetic variant that appears to protect against the development of CHIP, a phenomenon that can lead to ...

Some problems grow quietly, almost politely, until they stop being ignorable. Space junk is one of those. It does not ...

Whoop’s test, in comparison, starts at $349 for two per year, and unlike with Oura, you can upload tests done through your ...